🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
pharmacokinetics/pharmacodynamics of GX-G3 after single subcutaneous admini...
Status
Completed
Location
Chungnam National University Hospital
Start Date
2013-09
Trial ID
NCT01951027